ArticleJournal of molecular histology2026
Alveolar socket preservation with human umbilical cord mesenchymal stem cell-seeded hydroxyapatite-chitosan scaffolds: An in vivo assessment of osteoprotegerin and receptor activator of nuclear factor-κB expression.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tooth extraction is a common procedure often followed by alveolar bone resorption, which may compromise future implant placement, prosthetic rehabilitation, esthetics, and periodontal support. Hydroxyapatite-chitosan (HA-Chi) scaffolds combined with human umbilical cord mesenchymal stem cells (hUCMSCs) may enhance bone healing by modulating bone remodeling pathways. This study evaluated the effects of hUCMSC-seeded HA-Chi scaffolds on osteoprotegerin (OPG) and receptor activator of nuclear factor-κB (RANK) expression during alveolar socket healing. In this randomized controlled in vivo experiment, 45 male Wistar rats underwent mandibular incisor extraction and were allocated to three groups: untreated control (C), HA-Chi scaffold only (T1), and hUCMSC-seeded HA-Chi scaffold (T2). Each group included 15 animals, with five evaluated at 7, 14, and 28 days. OPG and RANK expression were assessed immunohistochemically and data were analyzed using one-way ANOVA followed by Tukey's post hoc test. OPG expression increased progressively over time in all groups, whereas RANK expression decreased. The hUCMSC-seeded HA-Chi scaffold group consistently showed the highest OPG and lowest RANK expression at all observation periods. Overall intergroup differences were significant for both markers (p < 0.001). For OPG, no significant difference was observed between T1 and T2 at day 7, whereas significant differences emerged at days 14 and 28. For RANK, the hUCMSC-seeded group showed significantly lower expression than the control group at all-time points and than the scaffold-only group at day 28. hUCMSC-seeded HA-Chi scaffolds promoted a favorable bone remodeling profile by upregulated OPG and downregulated RANK, indicating strong potential for alveolar socket preservation after tooth extraction.
Indexed as
Identifiers
42350708What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.